Gunst JD - Search Results

1

Evaluation and real-world experience of a neutralization susceptibility screening assay for broadly neutralizing anti-HIV-1 antibodies.

Pahus MH, Zheng Y, Olefsky M, Gunst JD, Tebas P, Taiwo B, Søgaard OS, Peluso MJ, Lie Y, Reeves JD, Petropoulos CJ, Caskey M, Bar KJ. Pahus MH, et al. Among authors: gunst jd. J Infect Dis. 2024 Oct 23:jiae486. doi: 10.1093/infdis/jiae486. Online ahead of print. J Infect Dis. 2024. PMID: 39441137

2

Central nervous system infections among individuals with and without end-stage renal disease.

Gunst JD, Jensen-Fangel S, Jespersen B, Ostergaard L, Søgaard OS. Gunst JD, et al. J Infect. 2013 Jul;67(1):19-26. doi: 10.1016/j.jinf.2013.03.006. Epub 2013 Mar 30. J Infect. 2013. PMID: 23549040

3

Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.

Højen JF, Rasmussen TA, Andersen KL, Winckelmann AA, Laursen RR, Gunst JD, Møller HJ, Fujita M, Østergaard L, Søgaard OS, Dinarello CA, Tolstrup M. Højen JF, et al. Among authors: gunst jd. Mol Med. 2015 Apr 14;21(1):337-45. doi: 10.2119/molmed.2015.00031. Mol Med. 2015. PMID: 25879630 Free PMC article.

4

The potential role for romidepsin as a component in early HIV-1 curative efforts.

Gunst JD, Tolstrup M, Rasmussen TA, Søgaard OS. Gunst JD, et al. Expert Rev Anti Infect Ther. 2016;14(5):447-50. doi: 10.1586/14787210.2016.1164031. Epub 2016 Mar 24. Expert Rev Anti Infect Ther. 2016. PMID: 26953620 No abstract available.

5

Beyond antiretroviral therapy: early interventions to control HIV-1 infection.

Gunst JD, Tolstrup M, Søgaard OS. Gunst JD, et al. AIDS. 2017 Jul 31;31(12):1665-1667. doi: 10.1097/QAD.0000000000001524. AIDS. 2017. PMID: 28463884 No abstract available.

6

Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation.

Gunst JD, Kjær K, Olesen R, Rasmussen TA, Østergaard L, Denton PW, Søgaard OS, Tolstrup M. Gunst JD, et al. J Virus Erad. 2019 Sep 18;5(3):133-137. doi: 10.1016/S2055-6640(20)30042-X. J Virus Erad. 2019. PMID: 31700655 Free PMC article.

7

The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies.

Martinsen JT, Gunst JD, Højen JF, Tolstrup M, Søgaard OS. Martinsen JT, et al. Among authors: gunst jd. Front Immunol. 2020 Jun 11;11:1112. doi: 10.3389/fimmu.2020.01112. eCollection 2020. Front Immunol. 2020. PMID: 32595636 Free PMC article. Review.

8

Broadly neutralizing antibodies combined with latency-reversing agents or immune modulators as strategy for HIV-1 remission.

Gunst JD, Højen JF, Søgaard OS. Gunst JD, et al. Curr Opin HIV AIDS. 2020 Sep;15(5):309-315. doi: 10.1097/COH.0000000000000641. Curr Opin HIV AIDS. 2020. PMID: 32675575 Review.

9

HIV-1 acquisition in a man with ulcerative colitis on anti-α4β7 mAb vedolizumab treatment.

Gunst JD, Schleimann MH, Pahus MH, Østergaard L, Tolstrup M, Søgaard OS. Gunst JD, et al. AIDS. 2020 Sep 1;34(11):1689-1692. doi: 10.1097/QAD.0000000000002619. AIDS. 2020. PMID: 32769767 No abstract available.

10

Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety.

Breining P, Frølund AL, Højen JF, Gunst JD, Staerke NB, Saedder E, Cases-Thomas M, Little P, Nielsen LP, Søgaard OS, Kjolby M. Breining P, et al. Among authors: gunst jd. Basic Clin Pharmacol Toxicol. 2021 Feb;128(2):204-212. doi: 10.1111/bcpt.13533. Epub 2020 Nov 22. Basic Clin Pharmacol Toxicol. 2021. PMID: 33176395 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters